Exicure
XCUR • NASDAQ
Exicure is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jungsoo Kim, with a market cap of $28.1M.
CEOJungsoo Kim
Next Earnings
No upcoming earnings scheduled for Exicure
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for Exicure
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.22 | — | - | — | — |
| Nov 7, 2025 | Q3 2025 | -$0.39 | — | - | — |  10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.41 | — | - | — | 10-Q |
| Jun 27, 2025 | Q1 2025 | $0.49 | — | - | — | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$3.39 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.57 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.35 | — | - | — | 10-Q |
| Jun 17, 2024 | Q1 2024 | -$0.50 | — | $500.0K | — | 10-Q |
| Jun 6, 2024 | Q4 2023 | -$0.65 | — | - | — | 10-K |
| May 16, 2024 | Q3 2023 | -$3.05 | — | - | — | 10-Q |
| Aug 11, 2023 | Q2 2023 | -$3.40 | — | - | — | — |
| Jul 14, 2023 | Q1 2023 | -$3.50 | — | - | — | — |